AI-Assisted Early Diagnosis of Alzheimer’s Disease: A Clinical Evaluation of Machine and Deep Learning Models
Biomedical & Pharmacology Journal · 02.06.2026 · 01_Special issue (19) · 1089
DOI: 10.13005/bpj/3411 ↗Kurz gefasst
Fachartikel in der Zeitschrift Biomedical & Pharmacology Journal, online erschienen am 01.06.2026. Verfasst von Safdar Sardar Khan und 5 weiteren Autor:innen. Die Arbeit nennt 43 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Themen: Demenz
Abstract (Originalsprache)
This study aims to evaluate the clinical efficacy of machine learning and deep learning models, particularly EfficientNetB7, for the early diagnosis of Alzheimer's disease using neuroimaging and clinical data. Machine learning and deep learning approaches to evaluate complex data, including neuroimaging and clinical information, aiding in the timely detection of Alzheimer's disease and delivering precise diagnoses. Machine learning algorithms, through comprehensive analysis of diverse data sources, have the capacity to discern intricate patterns and features that may elude human observation. Through training on extensive datasets, these models achieve heightened accuracy and improved generalization in diagnosing Alzheimer's disease. Deep learning, a subset of machine learning characterized by neural networks with numerous layers, enhances the capacity to decipher and extract nuanced patterns from extensive and intricate datasets. The development of reliable machine learning and deep learning models holds significant potential for enhancing early detection, a pivotal factor for timely interventions and appropriate treatment plans. Early diagnosis can lead to more effective disease management, maybe improving the standard of life for those suffering from Alzheimer's disease and reducing the strain on the healthcare system and carers. In a performance evaluation, the EfficientNetB7 model demonstrated exceptional accuracy, achieving a score of 99.36%. This underscores its superior performance in comparison to other models. Furthermore, it displayed a validation accuracy of 49.48%, showcasing its robustness and capability. The model maintained a validation loss of 2.9, while the training loss was impressively low at 0.017. When benchmarked against other machine learning models, EfficientNetB7 consistently outperforms, underscoring its potential for elevating diagnostic accuracy in Alzheimer's disease detection.
Zitieren
APA
Khan, S. S., Beg, R., Parmar, S., Khan, M. I., Deo, A., & Akhtar, S. (2026). AI-Assisted Early Diagnosis of Alzheimer’s Disease: A Clinical Evaluation of Machine and Deep Learning Models. Biomedical & Pharmacology Journal, 01_Special issue(19), 1089. https://doi.org/10.13005/bpj/3411
Vancouver
Khan SS, Beg R, Parmar S, Khan MI, Deo A, Akhtar S. AI-Assisted Early Diagnosis of Alzheimer’s Disease: A Clinical Evaluation of Machine and Deep Learning Models. Biomedical & Pharmacology Journal. 2026;01_Special issue(19):1089. doi:10.13005/bpj/3411
BibTeX
@article{Khan2026,
author = {Khan, Safdar Sardar and Beg, Rijvan and Parmar, Shredha and Khan, Mohammed Irfan and Deo, Arpit and Akhtar, Sadaf},
title = {AI-Assisted Early Diagnosis of Alzheimer’s Disease: A Clinical Evaluation of Machine and Deep Learning Models},
journal = {Biomedical & Pharmacology Journal},
year = {2026},
volume = {01_Special issue},
number = {19},
pages = {1089},
doi = {10.13005/bpj/3411}
}
EUVIMED